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INTRODUCTION
Asthma is a chronic inflammatory disease of the airways char-
acterized by airway obstruction, which is at least partially re-
versible with or without medication, and increased bronchial 
responsiveness to a variety of stimuli. Asthmatic patients are 
frequently bothered by recurring and varying symptoms of 
breathless, wheezing, cough and chest tightness. Asthma is of-
ten associated with allergy, an acquired potential for develop-
ing adverse reaction that are immunologically mediated. Ato-
py, an adverse immune reaction involving IgE antibodies, is be-
lieved to the strongest identifiable predisposing factor for the 
development of asthma.
1 Asthma affects more than 22 million 
persons, and is one of most common chronic diseases of child-
hood affecting more than 6 million children in the United 
States. 
Asthma and allergic diseases are believed to be complex ge-
netic diseases, which result from the interaction of multiple 
genes and environmental stimuli. Family studies indicated that 
the first degree relatives of individuals with asthma are about 
5-6 times risk of asthma than the individuals in the general 
population.
2 Family aggregation and segregation of asthma and 
allergy showed no consistency across diverse populations sug-
gesting the operation of complex and perhaps multiple genetic 
and environmental etiological factors. Heritability, the propor-
tion of phenotypic variances that caused by genetic effects, var-
ies from study to study in asthma. Multiple independent twin 
studies in diverse populations showed the heritability for asth-
ma ranges between 0.48 and 0.79 indicating significant genetic 
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effects contributed to asthma development.
3 The genetic factor 
may account for 40% to 60% of variance in allergen specific IgE 
level, 30% in log eosinophil count and 30% to 60% in positive 
skin test to dust mite in etiology.
4 The remainder of atopy and 
asthma etiology is therefore attributable to environmental vari-
ables and partly interactive gene-environment influences. In 
past decades, great efforts have been exerted in unraveling the 
genetic basis of asthma and allergic diseases. This review is in-
tended to briefly summarize what have been done and achieved 
in discovering, confirming genes and genetic variants and cur-
rent consensus on genetics of asthma. 
DISCOVERING GENE AND GENETIC VARIANTS OF 
ASTHMA AND ALLERGIC DISEASES
Several strategies have been applied to identify genes and ge-
netic variants that predispose to asthma and allergic diseases. 
These mainly include positional cloning, candidate gene ap-
proach, genome wide association study as depicted in Fig. 1. 
Positional cloning 
Positional cloning is a popular approach used to identify genes 
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for genetic diseases through a set of genetic markers on sus-
pected chromosomes. It is also termed genome scan or ge-
nome wide linkage study when the entire genome is screened 
using dense panels of polymorphic DNA markers spaced 
across the genome to identify specific regions for phenotypes. 
Positional cloning is very useful to identify a disease gene or 
disease susceptibility gene location in genome especially when 
unknown genetic information is available for the pathological 
mechanism of a disease. The genome screening is followed by 
identification of the gene (or genes) within this region, as well 
as polymorphisms within the gene(s) that contribute to the de-
velopment of a disease. The big advantage for positional clon-
ing in complex genetic diseases such as asthma and allergy is 
that it can identify a previously unknown gene or a gene not 
considered as candidate gene. 
Positional cloning is based on family study and linkage analy-
sis.
5 Collecting phenotypic data in pedigrees of multiple fami-
lies is a prior requirement for positional cloning. Polymorphic 
markers are DNA segments with multiple alleles that can be 
easily traced through multiple generations, and are chosen to 
cover the whole genome over certain physical distance (1-10 
cM) or on suspected linkage regions. The cosegregation of the 
polymorphic markers and a disease trait is examined within 
families to determine whether a marker is linked to a specific 
disease trait. Due to recombination events during meiosis, the 
closer two loci: polymorphic marker and disease trait are to 
each other, the smaller the chance of recombination is, and the 
greater the chance that the markers segregate with the disease 
is. A statistical indicator, lod score that refers to the log of the ra-
tio of the likelihood that the disease is genetically linked versus 
no linkage, has been widely adopted for evidence of linkage.
Positional cloning studies linked multiple regions of chromo-
somes to asthma and atopy related phenotypes in diverse pop-
ulations although most of them have largely focused on Cauca-
sian population. The followed studies identify genes and genet-
ic variants in these regions associated with asthma and allergy. 
The most recently found genes include ADAM33 on Chromo-
some 20p,
6 SPRINK5 on 5q31-35,
7 IRAKM on 12q,
8 DPP10 on 
2q14-32,
9 GPRA on 7p,
10 HLA-G on 6p21
11 and PHF11 on 13q14.
12 
ADAM33 is one member of metalloproteinase family preferen-
tially expressed in smooth muscle, myofibroblasts and fibro-
blasts rather than epithelial cells, T cells or inflammatory leuko-
cytes, and is believed to play an important role in epithelial-
mesenchymal tropic unit in lung development.
13 The impor-
tance of its genetic variants in asthma has been testified in repli-
cated association studies across diverse populations.
14 SPRINK5 
encodes a multi domain serine protease inhibitor which pro-
tects the integrity of epidermal layer from allergen or inflam-
matory related protease. Functional changes associated with 
genetic variant may account for its importance in asthma and 
allergy.
7,15 IRAKM encodes a kinase, a master regulator of NFkB 
and inflammation, negatively regulating TLR and IL1R path-
way. IRAKM is highly expressed in epithelial cells. Genetic vari-
ants including SNPs and haplotypes have been associated with 
early onset of asthma.
8 DPP10 was identified as an asthma re-
lated gene after resequencing the IL1 cluster region on 2q14. 
DPP10 functions in cleaving the terminal of dipeptides from cy-
tokines and chemokines as its homologous family members.
9 
Adopting hierarchical genotyping design leads to the identifi-
cation of GPRA which is associated with both IgE and asthma, 
suggesting a possible role in pathogenesis of asthma and ato-
py.
10 HLA-G is a non-classic, class I HLA molecule on chromo-
some 6p21. Expression of HLA-G was detected in bronchial ep-
ithelial cells of asthmatic patients rather than unaffected indi-
vidual.
11 A SNP in the 3’ untranslated region of HLA-G was 
shown to influence the targeting of three microRNAs to this 
gene, suggesting that microRNA mediated mechanisms may 
contribute to the impact of HLA-G on asthma risk.
16 PHF11 en-
codes two PHD zinc fingers which can interact with the trim-
ethylated lysine residue 4 on histone 3, a modification that 
marks transcriptionally active regions of the human genome. 
Quantitative trait locus for total serum IgE was localized around 
chromosome 13q14 using a comprehensive SNP map that 
leads to several alleles in PHF11.
12 PHF11 has been demon-
strated to be an important regulator of Th1 differentiation for 
IFN and IL2 expression. The reduction of PHF11 expression as-
sociated with genetic variants may contribute to increased Th2 
differentiation. 
The application of genetic linkage analysis in asthma and al-
Fig. 1.  Flowchart for unraveling genetic basis of asthma and allergic diseases. 
Susceptible genes are identified through positional cloning, candidate gene ap-
proach or genome wide association studies. Independent replications in diverse 
populations and functional studies for understanding the biological pathways 
and molecular mechanisms involved provide convincing evidences in the confir-
mation of a susceptible gene and the related genetic variants for asthma and 
allergic diseases. 
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lergy faced more difficulties than its application in simple Men-
delian disorders likely because of the possible genetic complex-
ity for asthma and allergic diseases. Different chromosome re-
gions have been linked to asthma and atopy related pheno-
types across diverse populations suggesting the genetic hetero-
geneity for these phenotypes which means many genetic back-
grounds may be involved. It is very common that more than 
one susceptibility locus were found in many of the linkage re-
gions. The linked region on chromosome 5q31-35 has been 
found to harbor multiple asthma and atopy genes which play 
various roles in the pathological mechanisms.
17 These include 
genes regulating Th1 and Th2 differentiation and IgE produc-
tion e.g. IL4, IL13, TIM1 and TIM3, genes modulating innate 
immunity e.g. CD14, genes controlling smooth muscle relax-
ation e.g. ADRB2, genes improving T cell adhesion e.g. CYFIP2, 
genes mediating inflammation process e.g. LTC4S, and genes 
influencing epidermal differentiation e.g. SPINK5. The effect of 
each linkage is relatively small compared to simple Mendel ge-
netic disorder, and the development of asthma and atopy in 
any individual seems to derive from genetic effects at a number 
of loci. Multiple genetic factors are believed to contribute to 
asthma and allergy therefore suggesting polygenetic effect. 
Candidate gene approach
The candidate gene approach is based on selection of a gene 
which is potentially involved in pathology of diseases and con-
sequently testing the linkage or association of their genetic vari-
ants with diseases. Genetic association analysis is the most 
popular design in candidate gene studies in which the co-inci-
dence of a disease and a genetic variant in a population is eval-
uated. The association study can detect genes with smaller ef-
fects in sample sizes comparable to those used in linkage stud-
ies, and statistically more powerful.
18 As the gene function is 
generally known, the association study is limited by its power to 
find a new gene or unidentified pathway for diseases. 
Candidate genes in asthma studies were selected based on 
hypothesis for asthma related functions either because these 
genes are localized in a linked chromosome region or there are 
evidences to support that they may be involved in important 
signaling pathways for asthma. The genetic variants to be tested 
for association with asthma are either derived from the known 
databases e.g. dbSNP or are identified through gene sequenc-
ing. The tested genetic variants were genotypes or alleles on 
SNPs (single nucleotide polymorphisms) around the candidate 
gene and haplotypes which are combination of alleles at near-
by variants. Recently, structural genetic variation especially 
copy number variation which refers to variable copy number of 
1 kb or larger DNA segment compared to a reference genome 
has attracted much attention in the genetic study for complex 
diseases too.
19
Case control design is preferable to family design in associa-
tion studies because recruiting unrelated cases and controls is 
easier and less expensive than recruiting families.
20 Association 
studies were performed to compare the frequency of specific 
polymorphisms mostly genotypes and haplotypes in the candi-
date genes in unrelated asthmatic (and/or allergic disease) pa-
tients and unrelated control samples, or to test whether the al-
leles at one or more SNPs explain the variability of a disease-re-
lated quantitative trait such as IgE level. The odds ratio (OR) 
value was usually used to estimate the asthma risk associated 
with specific genotype or haplotype while the regression coeffi-
cient in a regression model was estimated for the quantitative 
traits. The statistical significance, in which inflated type error I 
in multiple comparisons was overcome by Bonferroni correc-
tion and permutation test, suggested an association of specific 
genetic polymorphism with asthma and related phenotype.
21 
However, the observed association may be caused by linkage 
disequilibrium because the observed polymorphism is physi-
cally close to the DNA sequence that is actually important in 
causing the disease and therefore coherent together. 
Over last decades, many genes have been examined for an as-
sociation with asthma and atopy related phenotypes in diverse 
ethnic populations. Several excellent reviews have been pub-
lished in this filed.
20-23 More than 100 genes involved in patho-
genesis of asthma have been found significant association. 
More than 30 genes have been associated with asthma or atopy 
related phenotypes in five or more independent studies. Over 
14 genes including ADRB2, IL4R, HLA-DRB1, IL13, CD14, IL4, 
TNFα, FceRIB, ADAM33, IL10, STAT6, LTA, GSTP1 (Glutathi-
one S-transferase P1), CCL5 (CC-chemokine ligand 5, RANT-
ES) have been replicated in more than ten independent stud-
ies. These genes are mainly involved either in environment in-
teraction (CD14, GSTP1), antigen presentation (HLA-DRB1), 
Th2 cell differentiation (IL4, IL13, IL4R, STAT6), immunoregu-
latory (IL10, LTA, CCL5), tissue remodeling (ADAM33) or for 
respiratory smooth muscle relaxation (ADRB2). A recent com-
prehensive analysis of candidate genes examined in past 
through a GWAS database suggested that candidate genes in-
cluding TGFb1, IL1RL1, IL18R1, and DPP10 were the most sig-
nificantly associated with asthma.
24 
It has been observed that no one single gene showed signifi-
cant association in all studies suggesting the complex genetic 
etiology of asthma and atopic diseases. This may mean that no 
one single gene will be the asthma gene in all populations. It is 
therefore reasonable to deduce that the number of genes in-
volved in each individual will be fewer than all number of sus-
ceptible genes for asthma derived from population studies. 
Genome wide association study
With the development of genotyping technology, many hun-
dreds of thousands even millions of SNPs across the whole ge-
nome can be tested in a single gene chip.
25 The most common 
genetic variants associated with disease are expected to be 
identified in genome wide association study (GWAS). GWAS Meng et al. Volume 2, Number 4, October 2010
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studies offer an opportunity to explore the genetic basis of a 
complex disease in a comprehensive way, and not only have 
advantages over traditional candidate association studies in 
that they can discover truly novel disease candidate genes and 
pathways, but also have advantages over linkage studies in that 
it will identify genes and genetic variants with small effects.
26 It 
is expected that GWAS study may become a standard approach 
to gene discovery over the next decade when the financial costs 
and computational limits are overcome. 
The first GWAS study about asthma was published in 2007.
27 
More than 317K SNPs were scanned in genomic DNA from 994 
patients with childhood onset asthma and 1,243 non asthmat-
ics, using both family and case-control panels. The strongest as-
sociation was located to 112 kb interval on chromosome 17q21 
and significantly replicated in several different populations. The 
trait-associated markers fall in the region containing three con-
secutive haplotype blocks. Multiple SNPs seem to jointly con-
tribute to disease risk in a forward stepwise regression analysis 
indicating more than one functional SNP underlie the locus or 
less likely the presence of a single functional SNP in complete 
linkage disequilibrium with the typed markers. The study in 
EBV transformed B cell lines showed that an identified SNP was 
associated with gene expression level of ORMDL3 (ORM 1 like 
3) in the region, a novel transmembrane protein anchored in 
the endoplasmic reticulum with unknown function. The 
ORML3 transcript expression was also simultaneously associ-
ated with asthma. The association of the genetic variants in 
gene ORMDL3 with childhood onset asthma has been success-
fully replicated in multiple populations with various ethnic 
backgrounds.
28-30 The common genetic variants seem to be as-
sociated with chromatin remodeling such as nucleosome dis-
tribution, binding with the insulator protein CTCF (11 zinc fin-
ger transcriptional repressor) as well as promoter activity lead-
ing to altered domain-wide cis-regulation in a recent functional 
study.
31 
Another GWAS study in the Hutterites,
32 a founder population 
of European descents, found that CHI3L1 variants were associ-
ated with asthma and related phenotypes. CHI3L1 (the chi-
tinase 3-like 1) encodes a chitinase like protein YKL-40 which 
may be involved in inflammation and tissue remodeling due to 
its ability to bind ubiquitously expressed chitin. Its findings re-
main to be replicated in more independent studies although it 
has not been replicated in a recently published GWAS study.
33 
A GWAS study conducted by Himes
33 in CAMP (childhood 
asthma management program) and matched control indicated 
that the strongest region of association was located to chromo-
some 5q12 in PDE4D (phosphodiesterase 4D, cAMP-specific 
phosphodiesterase E3 dunce homolog). PDE4D is a regulator 
of airway smooth muscle contractility associated with cAMP.
33 
PDE4D inhibitors could suppress the activation of inflammato-
ry and resident cells in lung in response to various stimuli as in 
asthma, and are being developed as medications for asthma.
34 
The genetic variants of PDE4D associated with asthma could be 
another important mechanism accounting for the hyperre-
sponsiveness in respiratory tract in asthmatic patients. A GWAS 
study conducted by Hancock et al.
35 in Mexican children with 
asthma using 550K Illumina HumanHap Beadchip identified 
novel genetic variants for childhood asthma in chromosome 
9q21. The SNPs located upstream of TLE4 (transducin like en-
hancer of split 4 gene) were replicated to be associated with 
childhood asthma risk in Mexican ethnicity. TLE4 encodes a 
transcriptional co-repressor which interacts with the transcrip-
tion factor paired box 5 for B cell activation in early B cell differ-
entiation, and interacts with RUNX3 (runt related transcription 
factor 3) in dendritic cells to inhibit dendritic cell matura-
tion.
36,37 These interactions are related to atopy and asthma de-
velopment. TLE4 associated genetic variants may influence 
asthma through its possible impact on immune system devel-
opment. Except asthma as the main phenotype, a GWAS scan 
on total serum IgE levels by Weidinger identified FceRIA (alpha 
subunit of FceRI) as a susceptible gene in birth cohorts and 
cross-sectional studies of European decedents.
38 The top genet-
ic variants have also been associated with FceRIA expression 
on Basophils through gene expression arrays. In addition, ge-
netic polymorphisms in RAD 50 gene, which is located close to 
well replicated linkage region on chromosome 5q31, were also 
consistently associated with IgE levels and increased risk for 
atopic eczema and asthma. RAD50 encodes a ubiquitously ex-
pressed DNA repair protein, and contains multiple conserved 
non-coding sequences with presumed regulator function for 
Th2 cytokine gene transcription. RAD50 was also noticed in 
strong linkage disequilibrium with other Th2 cytokines such as 
IL13, etc.
39,40 Whether genetic variants of RAD50 are directly re-
lated to IgE production or because of its linkage with Th2 cytok-
ines remains to be elucidated in future. A recent GWAS study in 
African population identified 3 genes as associated with asth-
ma including ADRA1B, PRNP and DPP10.
41 Except DPP10, 
ADRA1B and PRNP are the first reported to be potentially in-
volved in asthma pathology although their possible roles in 
asthma remain to be explored. In a recent GWAS carried out in 
a combined population of European ancestry children with 
persistent asthma, several SNPs at a novel locus on 1q31 were 
found to be most significantly associated with asthma in addi-
tion to the previously reported locus on 17q21.
42 The associa-
tion was also replicated with asthma in both independent se-
ries of persons of European ancestry with childhood onset 
asthma and in the children of African ancestry. The most 
strongly associated markers implicate DENND1B as a suscepti-
ble gene for asthma. DENND1B encodes a cytosolic signaling 
protein which is a binding partner of TNF-α receptor type I 
binding protein, and negatively regulate TNFR1 signaling in re-
sponse to cytokine promoted stress.
43 The DENND1B protein is 
expressed in a subgroup of dendritic cells and in natural killer 
cells, and significantly upregulated in effector memory T cells Review on Genetics of Asthma AAIR 
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as compared with nai_ve T cells.
44,45 Its roles in asthma patholo-
gy remain to be delineated in future. 
Overall, GWAS studies up to date have generated many inter-
esting findings. Novel genes and pathways have been revealed 
including ORMDL3, DENND1B etc although the importance of 
these findings in asthma and allergy remains to be verified in 
more replicated population studies and functional genomic 
studies. GWAS studies are also limited in its power to discover 
genes for complex genetic diseases because the current GWAS 
arrays are biased toward common targeting variants rather 
than relatively rare SNPs in coding and promoter regions in 
their SNP genotyping panels. It has been hypothesized that nu-
merous rare functional SNPs may be important in susceptibility 
to common diseases such as asthma. The design of GWAS ar-
rays based on mostly Caucasian populations may also be bi-
ased and influence the discovery of new genes in other ethnic 
populations. 
CONFIRMING SUSCEPTIBLE GENE AND GENETIC 
VARIANTS FOR ASTHMA AND ALLERGIC DISEASES
To be truly susceptible genes and genetic variants for asthma, 
strong evidences from both independently replicated studies 
for association and linkage, and related functional changes are 
required. However, many uncertainties are involved in replicat-
ed population studies and functional genomics investigation. 
These added to the complexity of asthma genetic and worth of 
further discussion in confirming susceptible genes and genetic 
variants for asthma.
Replication studies
Independent replications of genotype-phenotype association 
in distinct populations have been considered important con-
vincing evidences for the identification of true disease suscepti-
bility genes. As we know, genotype is determined by allele vari-
ants in a specific locus. Haplotype has been used more fre-
quently in recent reports of association. Multiple genetic poly-
morphisms are located in most genes. It is common that an al-
lele or haplotype, which was reported positive association in an 
original study, could not be found to be associated with asthma 
or atopy related traits even with opposite effect in replicated re-
ports. On the other hand, the nearby alleles or different haplo-
types on the same gene could be found significance in replicat-
ed studies. As diverse asthma and atopy related phenotypes 
have been utilized, strict or loose replication has been used to 
define the genotype-phenotype relationship: strict, genotype 
strict, phenotype strict or loose.
46 Gene itself rather than specif-
ic genetic variants or haplotypes has been recommended as a 
unit in defining a replication.
47 
The results from independent replications are impacted by 
many factors in distinct populations. These include but not ex-
clusively phenotype heterogeneity, gene-gene interaction, gene-
environment interaction, race/ethnicity, epigenetic effect, study 
design such as cohort type and sample size for statistical power.
Phenotypes
Phenotype refers to genetically and environmentally deter-
mined physical appearance of diseases. Similar to other com-
plex diseases, asthma and allergic diseases are phenotypically 
heterogeneous and characterized by diverse clinical aspects, 
varied susceptibility to stimuli and numerous intermediate 
phenotypic markers for physiological and histopathological 
changes.
48 The distinct clinical features include onset age, tran-
sient or persistent status, severity degrees, therapy response 
and concurrent disease status etc. The individual manifestation 
is derived from any combination of these features, and may be 
determined by specific subsets of susceptible genetic pathways. 
Various asthma and atopy related phenotypes have been used 
in published literatures including various disease statuses such 
as asthma, atopy, childhood asthma, atopic dermatitis, hay fe-
ver, asthma severity and intermediate or associated phenotypes 
such as allergic sensitization, bronchial hyper responsiveness, 
FEV1, IgE level, eNO and eosinophil counts.
20 The phenotype 
definition and criteria should be taken into account in evaluat-
ing a replication study. 
Gene-gene interaction
Interaction is a term used to describe the relationship be-
tween two factors in terms of effects on an observed endpoint, 
in which the effect of one factor is conditional on another one. 
Gene-gene interaction refers to the functional interplay be-
tween genetic variants in related genes, also called epistatic in-
teraction. Among multiple possible interaction scenarios, the 
synergistic effects in which the combined asthma risk of genet-
ic variants exceeds the additive effect of two genetic variants 
presence alone has received greater interests in explaining the 
functional relevance of potential asthma related genetic vari-
ants. A good example is an interaction between different poly-
morphisms in the Th2 differentiation pathway significantly in-
fluencing the genetic control of serum IgE levels and the devel-
opment of asthma.
49 The analysis of genotyping data in step-
wise procedure from a large population of German children 
showed that the combined effects of three genetic variants 
comprised of T allele in STAT6 C2892T, T allele in IL13 C1112T, 
and T allele in IL4 C589T increased the risk of asthma by 16.8 
fold compared to maximum effect of any individual SNP and 
by 5.89 fold compared to maximum effect of any combination 
of two SNPs. The risk of elevated serum IgE levels increased 
from the maximum single effect of OR 1.73 for STAT6 C289T to 
a maximum of 18.73 for the triplet interaction among T allele in 
IL13 C1112T, G allele in IL4R A148G and IL4 C589T. The inter-
actions of IL13 and CCL17 for total IgE level,
50 IL4Rα and IL13 
for asthma risk,
51 and IL13 and IL4Rα for food sensitization
52 
have also been reported. It is expected that more genetic inter-Meng et al. Volume 2, Number 4, October 2010
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actions are involved in asthma and atopy, and remain to be ex-
plored. Therefore, the difference in allele frequency of known 
or unknown genetic variants with potential interaction will im-
pact the results in replicated studies, which adds to the genetic 
complexity of asthma.
Gene-environment interaction
It is clear that environmental factors such as virus, allergen ex-
posure and smoking etc are important determinants in the de-
velopment of asthma. Hygiene hypothesis of asthma suggests 
that exposure to infections early in life influences the develop-
ment of a child’s immune system along a “non-allergic” path-
way, leading to a reduced risk of asthma and other allergic dis-
eases.
53,54 Gene-environment interaction is believed to contrib-
ute to a proportion of the phenotypic variance significantly in 
animal study and evidenced from human studies too.
55,56 Inter-
action of CD14 with endotoxin exposure on asthma and IgE 
levels provides a good example to illustrate the importance of 
gene-environment interaction in asthma and allergic diseases 
and how the genetic effect might be impacted by environmen-
tal exposure.
57 CD14 is a receptor that has specificity for LPS 
(Lipopolysaccharides) and other bacterial well derived compo-
nents, and has also been suggested as a potential response ele-
ment for the respiratory syncytial virus. The global microbial 
burden in life, including exposure to nonpathogenic microbes, 
could deviate immune responses away from those associated 
with allergic responses through interaction with CD14. The as-
sociation of CD14C-159T with asthma related phenotypes 
seems to be a more complex story than expected from lots of 
epidemiological studies. The early study reported that atopic 
children with homozygous TT genotype had significantly 
smaller mean number of positive skin test to aeroallergens than 
CC homozygous suggesting that TT homozygous plays a pro-
tective role against allergy. The effects revealed by the following 
studies are diverse, ranging from protective to disease promot-
ing, with some reports failing to find an association. It seems 
that endotoxin exposure is one of the factors determining 
whether it could be either protective or risk promoting. Chil-
dren who were homozygous CC were associated with a de-
creased risk of allergic sensitization and eczema at high endo-
toxin exposures, but with an increased risk at low endotoxin ex-
posures relative to the rest of the population. The individuals 
with TT homozygous were protected from total IgE level at low 
level of endotoxin exposure and at increased risk at high level. 
This phenomenon was also observed in the association of CD14 
C-159T with asthma and asthma severity. House dust exposure 
is another factor that may be involved in the gene-environment 
interaction. TT genotype might protect against asthma for indi-
viduals with low house dust exposure, but be a risk factor of 
asthma with high house dust exposure although it is not clear 
whether there is a direct relationship between house dust level 
and endotoxin. Other examples include the interaction be-
tween tobacco smoke and GST and ADRB2,
58 between TLR2 
and farm living
59 etc. Gene-environment interactions are be-
lieved to be a framework to reconcile the discrepancies from 
replicated studies. As illustrated from functional studies, bind-
ing affinity of transcriptional factors such as SP1 and SP3 differs 
between C and T allele of CD14-159 probably resulting in 
change of gene expression. Environmental exposure may acti-
vate and impact the expression of various transcription factors 
in different cell types. As one of the mechanisms, both changed 
binding affinity associated with genotypes and varied level of 
transcription factors associated with environmental exposure 
may determine the consequences in gene-environment inter-
action. Environment factors have been associated with epige-
netic modification such as hypermethylation promoters and 
downregulating transcription of gene expression by ETS (envi-
ronmental tobacco smoke). The epigenetic mechanisms in-
cluding DNA methylation, histone acetylating and deacetyla-
tion, and other modes of chromatin remodeling associated 
with in utero and early life exposure to environmental factors 
may be involved in transgenerational phenotype transmission. 
Recently allele specific epigenetic modification has been iden-
tified for common genetic polymorphisms of gene ORMDL3.
31 
The epigenetic effects under various innate and environment 
exposures may be another possible mechanisms involved in the 
complex interplay among gene-environment interaction.
56,60 
Race/ethnicity
The genetic studies of asthma have been conducted in diverse 
racial/ethnic populations in past decades. Different results in 
terms of importance of certain genomic region, certain genes 
and their genetic polymorphisms in asthma have been ob-
served across racial/ethnic groups. The Collaborative Study on 
the Genetics of Asthma had identified the linkage between chro-
mosome 5p, 17q, and 11q21 with asthma in African Americans, 
chromosome 11p15, 19q13, and 6p21 in Caucasians, and chro-
mosome 2q33, 21q21, and 1p32 in Hispanics.
61,62 Multiple ge-
netic polymorphisms in gene ADAM33, IL4, and IL4R do not 
show consistent associations with asthma and allergen sensiti-
zation across the ethnical diverse populations (e.g. US whites, 
Dutch, African Americans, and Hispanics).
63 TGFβ1 is a multi-
functional cytokine which can be expressed in various inflam-
matory cells (e.g. T cells, B cells, Monocytes, Macrophages, eo-
sinophils, neutrophils, mast cells, dendritic cells), epithelial cells, 
fibroblasts, smooth muscle cells and endothelial cells. When se-
creted from these cells, TGFβ1 can modulate inflammation such 
as cellular proliferation, T cell differentiation, cell apoptosis and 
cell migration, and/or impact host resistance and mediate tis-
sue remodeling and repair in autocrine or paracrine manner 
through interaction with the TGFβ1 receptors. An Allele T at a 
SNP C-509T at promoter site of TGFβ1 has been significantly as-
sociated with higher risk of asthma in multiple Caucasian popu-
lations, but failed to show association in two East Asian popula-Review on Genetics of Asthma AAIR 
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tions.
64,65 The T allele frequency is almost two times in East Asian 
populations than in Caucasian populations. Our pilot study in-
dicated that T allele and the associated haplotype may protect 
from allergy in Chinese population but increase risk of allergy in 
White population (not published). The significance of this find-
ing remains to be explored in bigger populations. Significant ge-
netic variations across racial/ethnic groups have been described 
in multiple studies. This can be reflected from the fact that some 
rare disease susceptibility alleles (frequency<=2%) may be 
found only in certain ethnic groups while common disease sus-
ceptibility alleles in certain ethnic group may be less common 
in other groups.
66,67 Multiple socioeconomic, psychological, and 
environmental factors have been associated with asthma in ad-
dition to genetic factors.
68 There may be important differences 
in those factors among diverse ethnic groups and/or subgroups 
within an ethnic group. Therefore, the disease susceptibility al-
leles that are common in most ethnic groups may have differen-
tial effects on disease risk because of gene-gene and gene-envi-
ronment interaction that are unique or more common in cer-
tain ethnic groups. Furthermore, factors associated with place 
of birth might modify the effect of genetic and environmental 
exposures on asthma within or between ethnic groups. Mexi-
can Americans born in the United States have more than three 
times of asthma risk than those born in Mexico no matter males 
or females after adjusted age, BMI, smoking history and PIR 
(poverty income ratio) in the recent NHANES report.
69 Failure 
to stratify the study population by race/ethnicity or lack of ge-
nomic control in case-control association studies will cause the 
interpretation of replication result difficult.
The number of independent replications used for selection of 
the most susceptible genes varies among reviewers. It is gener-
ally agreed that the more replications are reported, the more im-
portant will the gene and the genetic variants be in the genetic 
complex diseases. Applying the replication number in deter-
mining the susceptibility of genes may be limited by how long 
since a gene was reported and whether the original result was 
positive or negative and how big the sample sizes are used in 
the replicated studies. If an important gene is recognized re-
cently or a negative result was reported in the original study, it 
is likely that there will be fewer replications in reports as expect-
ed. Many of the reported studies lack a sufficient sample size to 
generate a significant result especially for a modest effect. When 
multiple SNPs or alleles are involved, inflated type I error in 
multiple comparisons cannot be overcome in a small sample 
size study. Furthermore, the conclusion about the association 
from a small size study may not be generalized to a general pop-
ulation even though a significant effect can be seen. Due to link-
age disequilibrium among nearby genetic variants, many of 
which have been significantly associated with asthma and ato-
py related phenotypes might not be the disease variants rather 
than in LD with the disease variants. Therefore, functional stud-
ies are necessary to clarify the roles of susceptible gene and ge-
netic variants in asthma and allergic diseases.
Functional genomics
Disease susceptibility genes and genetic variants discovered 
through linkage or association study can be established through 
further functional characterization in in vitro, ex vivo or in vivo 
studies under imitated physiological environment and extrane-
ous stimulation. The functional genomics study can identify 
possible pathways involved and the molecular mechanisms ac-
counting for the roles of genetic variants, gene-gene and gene-
environment interaction in diverse phenotypic expressions in 
asthma and allergic diseases. Many genetic variants in suscep-
tible genes have been found to result in one or multiple func-
tional changes such as epigenetic effects, promoter binding af-
finity, splicing change, mRNA stability, amino acid change or 
microRNA dysfunctions. To illustrate the potential role of CD14 
C-159T in gene-environment interaction as described above, 
the functional genomic study showed that the constructs carry-
ing the T allele have higher transcription rates than those carry-
ing the C allele when transfected into a mononuclear cell line. 
Consistent results indicate that TT homozygous is associated 
with higher sCD14 than carriers of the other two genotypes. 
One hypothesis proposed by Marinez
57 was that endotoxin in-
duced CD14 synthesis could be higher in carriers of the C allele 
than in carriers of the T allele especially at high endotoxin ex-
posure making possible the protective effect for C allele, where-
as higher constitutive expression of CD14 in TT homozygous 
than in other genotypes might be more susceptible to the pro-
tective effects of low levels of microbial products that interact 
with CD14. CD23 is a IgE low affinity receptor which is believed 
to mediate various pathogenic functions in IgE mediated im-
munity including antigen focusing and presentation, regulating 
IgE synthesis, promoting T and B cell differentiation and growth, 
and inducing the production of proinflammatory cytokines. A 
non-synonymous SNP of CD23 with Arg to Trp exchange at po-
sition 62 (R62W: rs228173) has been associated with enhanced 
T cell response to antigen in allergic subjects by us. The substi-
tution of Trp for Arg seems to result in resistance of CD23 to en-
zymatic cleavage in transfected cell lines.
70 Therefore, the stabi-
lized form of CD23 with Trp may be more efficient for antigen 
presentation than the original form accounting for the observed 
difference in T cell response. The changed function may be as-
sociated with diminished N-glycosylation in CD23 with Trp. 
More functional studies are being conducted for understanding 
its significance in allergic reactions in our lab. 
The cytokine IL13 plays a critical role in Th2 response and in-
duces allergic inflammation and experimental asthma. Multi-
ple genetic variants in the promoter (C1112T: rs1800925; A-
1521C: rs1881457) and coding regions (G2044A: rs20541) have 
been associated with atopic asthma and non-atopic asthma, 
increased risk of sensitization to food and outdoor allergens, 
and bronchial hypersensitiveness in multiple studies.
52,71 Mo-Meng et al. Volume 2, Number 4, October 2010
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lecular modeling suggests that the substitution of the mildly 
acidic acidic amino acid glutamine (Gln) for the basic arginine 
(Arg) at position 144 (rs20541) might promote enhanced bind-
ing of the ligand to IL13 receptor through removal of a basic-
basic repulsion between Arg144 of IL-13 and His131 (histidine) 
of IL4Rα.
72 Subsequent functional studies on this variant sug-
gests, as an alternative, that the Gln 144 variant of IL13 may bind 
less avidly to the decoy receptor IL-13Rα2, thus upregulating the 
ligand’s availability and thus increasing the risk for asthma.
73 The 
functional study on SNP rs1800925 showed that -1112T allele 
enhanced IL13 promoter activity in primary and murine CD4+ 
Th2 lymphocytes. Increased expression of IL13 -1112T in Th2 
cells was associated with the creation of a Yin-Yang 1 binding 
site that overlapped a STAT motif involved in negative regula-
tion of IL13 expression and attenuated STAT6-mediated tran-
scription repression.
60 Recently, IL13 A-1521C is found to be a 
functional polymorphism that significantly enhances HS4-de-
pendent IL13 expression by creating a binding site for the tran-
scription factor Oct-1. It has been demonstrated that increased 
activity for IL13-1521C allele was exquisitely dependent on phys-
iological levels of Oct-1 by comparing the expression in transfect-
ed Th2 cells lines from Oct1+/+ mice and Oct1+/-.
74 These func-
tional studies on IL13 suggest that multiple genetic variants in 
one gene may be involved in the functional differences among 
individuals who may have different combination of these ge-
netic variants. If high linkage disequilibrium is taken into ac-
count, the individual with a haplotype with high risk alleles at 
multiple sites may have much higher risk of asthma due to syn-
ergistic at least additive effect. Genetic variant interaction could 
be another important factor to account for the complexity in 
confirming gene and genetic variants in asthma and allergic 
diseases. 
MULTIFACTORIAL GENETICS OF ASTHMA AND ALLERGIC 
DISEASES
It is now widely accepted that genetics of asthma and allergic 
diseases are multifactorial. No single gene or genetic variant 
can explain all even most of variances in the general population 
for asthma and allergic diseases. The genetic basis is interacted 
with environmental factors in the development of asthma and 
allergic diseases perhaps together with development factors. 
Therefore, we propose that the susceptible genes for asthma 
may be categorized into four main groups based on their major 
functions: Barrier layer and defense; Antigen recognition and 
presentation; Immunoregulation and Th2 differentiation; and 
Effecter targets as showed in Fig. 2.
Barrier layer and defense 
Skin, oral and bronchial epidermal are interfaces exposed to 
environmental agents. The integrity of the skin barrier is crucial 
for the interaction of host with environmental agents impacting 
the fate of future allergic reaction.
75,76 FLG (Filaggrin) is a mem-
ber of the epidermal differentiation complex expressed in the 
epidermis and in oral and nasal mucosa, but not in bronchial 
mucosa. FLG plays a crucial role for the integrity of the epitheli-
al barrier. Null mutation of FLG with the potential breakdown 
of the epidermal skin barrier may account for its high risk of 
atopic dermatitis and asthma reported in multiple studies.
77 
SPINK5 expression is restricted to the epithelial and mucosal 
surfaces and in the thymus. It plays a protective role against 
proteases existed in many allergens or released from mast cells. 
A mutation of SPINK5 has been associated with asthma and ec-
zema.
15 COL29A (collagen XXIX), an epidermal collagen, is 
highly expressed in the skin, lung and gastrointestinal tract and 
contributes to the epidermal integrity and function. The region 
with this gene on chromosome 3q21 was identified as a suscep-
tibility locus for atopic dermatitis by genome wide linkage anal-
ysis.
78 DEFB1 (Defensin β1) is one of defensins that are antimi-
crobial peptides secreted from epithelium and may take part in 
airway inflammation and hyperresponsiveness. Genetic vari-
ants esp. that in 5’ UTR of defensin β1 have been associated 
with asthma and related phenotypes in several cohorts suggest-
ing its important roles in the development of asthma and aller-
gy.
79,80 
Antigen recognition and presentation 
When allergens and pathogens penetrate the barrier layer, a 
variety of receptors existing in antigen presenting cells will rec-
Fig. 2.  Multifactorial genetics of asthma and allergic diseases. The genetic ba-
sis is interacted with environmental factors perhaps together with development 
factors in the development of asthma and allergic diseases. When gene-envi-
ronment interaction is taken into consideration, the identified susceptible genes 
are categorized into four groups with major functions in barrier layer and de-
fense, antigen recognition and presentation, immunoregulation and Th2 differ-
entiation, and effecter targets.
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ognize them. Binding with specific ligands will initiate immune 
responses through the release of numerous inflammatory me-
diators and cell-cell contact, and promote antigen presentation 
to T cells for further cell differentiation. Genetic variants in nu-
merous genes in this process have been associated with asthma 
and atopy related phenotypes suggesting their importance in 
allergic inflammation in the pathogenesis of asthma. This group 
of genes is composed of pattern recognition receptors either ex-
tracellular receptors such as CD14
57 and toll like receptors 
(TLRs)
81 or intracellular receptors such as NODs (nucleotide 
binding oligomerization domain),
82 IgE high affinity receptor 
(FceRI)
83 or low affinity receptor (FceRII, CD23),
70 and others 
such as PTGER2 (prostaglandin receptor),
84 HLA DRB1 gene,
85 
and TCR (T cell receptor).
86 Recognition of pathogenic organ-
isms by the innate immune system relies on pattern recogni-
tion receptors that detect preserved structures of bacteria, vi-
ruses, protozoa, and fungus, so-called pathogen-associated 
molecular patterns (PAMPs). TLR2 is involved in recognition of 
microbial motifs of a wide range of Gram-positive microorgan-
isms, mycobacteria, and yeast.
59,87 Heterodimers TLR1/2 and 
TLR6/2 seem to be necessary for TLR1 to function for activation 
by lipopeptides and TLR4-MD2 for LPS.
81 TLR1, TLR6, and 
TLR10 are closely located on Chromosome 4p14. They have 
been associated with asthma and atopy related phenotypes in 
various studies.
88 TLR9 is a receptor for bacterial CpG DNA mo-
tifs and may interact with genetic variants of TLR2 impacting 
asthma risk.
87 The nod-like receptors (NLRs) are a specialized 
group of intracellular receptors that recognize specific bacterial 
and endogenous molecules, and represent a key component of 
the host innate immune system. Intracellular sensors NOD1 
and NOD2 play a critical role in host defense when TLR signal-
ing is reduced, such as within the intenstine due to low expres-
sion levels of TLRs or after induction of tolerization by exposure 
to TLR ligands.
82 Certain genetic variants of NOD1 and NOD2 
were associated with an increased risk of developing asthma 
and atopic dermatitis or IgE level while some genetic variants 
of NOD1 were associated with a protective effect of exposure to 
a farming environment.
89,90 PTGER2 has special interests be-
cause it may interact with Pollen-associated phytoprostanes, 
the prostaglandin like bioactive molecules, which inhibit den-
dritic cell IL12 production and augment Th2 cell polarization.
91 
Variants of HLA DRB1 loci have been associated with specific 
allergen sensitization in different DR loci such as to ragweed, 
cockroach allergens and to clinical syndrome of allergic bron-
chopulmonary aspergillosis.
85 IgE specific receptors are critical 
in mediating allergic inflammation. Genetic variants in both 
IgE high and low affinity receptor have been linked and associ-
ated with asthma and atopy related phenotypes in various stud-
ies as well.
83,92 The genetic variants in these genes might play a 
specific role for high risk of asthma in response to a specific al-
lergen or an environmental factor. 
Immunoregulation and Th2 differentiation
The recognition and presentation of environmental antigens 
will initiate regulating ether innate or adaptive immunity which 
will play important roles in inflammation and other pathogenic 
processes in asthma and allergic diseases through the release of 
various mediators as mentioned above. Allergic inflammation 
is one of the characterized features resulting from the interac-
tion between environment and host in the pathogenesis of asth-
ma and allergy. Th2 differentiation is a crucial event in allergic 
inflammation reaction.
93 Th1 cells produce IFN-γ and IL12, and 
promote cellular immunity. Th2 cells produce predominantly 
IL4, IL5, IL13 etc, which induce allergic immune response in-
cluding IgE production and eosinophil activation. The differen-
tiation of T cells into Th1 or Th2 may be dictated by a complex 
network of antigens, characteristic of antigen presenting cells, 
and cytokine environment.
94 The associations of genetic vari-
ants in Th2 related genes such as GATA3, STAT6, IL4, IL4R, IL13, 
IL5, IL5R, and PHF11 and in Th1 related genes such as IL12b, T-
bet (T box transcription factor), HLX1 (homeobox transcription 
factor H.20 like homeobox 1), IRF (Interferon regulatory fac-
tor-1) with asthma and atopy related phenotypes have been re-
ported.
22 As various genes from different cell sources are in-
volved in regulating the development of Th2 cell differentiation, 
the genetic variants in genes such as TGFβ1, IL10, STAT3, CCL5, 
CCL11, CCL24, and DPP10 may play an important role in the 
pathogenesis of asthma too.
20,22 
Effecter targets 
The dominant physiological event in asthma is airway nar-
rowing and a subsequent interference with airflow. These result 
from bronchial smooth muscle contraction (bronchoconstric-
tion), persistent and more progressive inflammation with air-
way edema, hyperemia of the airway mucosa and infiltration of 
mucosa with inflammatory cells, thickened airway wall with 
deposition of type III collagen and tenascin below the true 
basement membrane.
1 In more severe asthma, thickening air-
way wall gets worse with hypertrophy and hyperplasia of air-
way glands and secretary cells, hyperplasia of airway muscle, 
blood vessel proliferation and dilation, and the further deposi-
tion of submucosal collagen. The inflammatory mediators in-
cluding chemokines, cytokines, cysteinyl-leukotrienes, IgE gen-
erated from various inflammatory cells specifically and interac-
tively contribute to this process in asthma. The genetic variants 
of genes involved in this process may impact the development 
of asthma at different stages. These genes include ADAM33 for 
tissue remodeling,
6 GSTM1, GSTT1, and GSTP1 for detoxifica-
tion of environmental and oxidative stress,
95 NOS1 for nitric ox-
ide synthesis,
96 LTC4s for cysteinyl-leukotrienes generation,
97 
ADRB2 for smooth muscle relaxation,
3 TNF for inflammation,
98 
FceRI for allergic mediators,
83 GPRA for regulation of cell 
growth and neural mechanisms,
10 CCL11 and CCL5 for eosino-
phil chemoattractant.
99 As it is a very complicated process, the Meng et al. Volume 2, Number 4, October 2010
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genetic variants in more genes remain to be explored in this 
process. It should be kept in mind that the above gene classifi-
cation is only for illustration purpose in the complexity of asth-
ma and allergic diseases. As one gene may own multiple func-
tions in the pathogenesis of asthma, the genetic variants in 
each gene may likely have multiple roles and therefore may 
play complicated roles in asthma and allergic diseases. 
CONCLUSION AND FUTURE PERSPECTIVES
Genetics of asthma and allergic diseases are multifactorial and 
are conditional on other factors such as environmental expo-
sure and race/ethnicity. In addition to what have been found, 
more genes and genetic variants will be identified in the patho-
genesis of asthma and allergic diseases in the coming years. The 
development of new technology such as high through put and 
low cost gene chip and next generation of DNA resequencing 
will expedite our efforts. The combination of genome wide asso-
ciation study with expression microarray analysis will be help-
ful for illustrating the mechanism in a comprehensive way. Due 
to the phenotype heterogeneity in published studies, a stan-
dardized definition for phenotypes in genetic studies of asthma 
and allergic diseases will be useful for comparison and further 
personalized medicine purpose. The collection of environmen-
tal exposure information will be necessary for understanding 
potential gene-environment interactions involved, and for com-
prehensively illustrating genetic effects of susceptible genes. 
Functional studies are important and necessary to understand 
the true molecular mechanisms involved in their genetic effects 
in asthma and allergic diseases. Biostatistics, and bioinformatics 
and system biology approaches are needed to handle with vast 
amounts of information and identify the constellation of genes 
in terms of environment interaction and gene–gene interaction 
perhaps associated with development stages. It is expected that 
unraveling genetics of asthma and allergic diseases significant-
ly improve prevention, diagnosis and treatment of asthma and 
allergic diseases in future.
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